Table 4.
Baseline features of 116 HBV infected patients enrolled in this study [median (min-max)].
| Clinical Features | R | CHB | LC | HCC |
|---|---|---|---|---|
| Number | 29 | 53 | 20 | 14 |
| Age (years) | 60 (25-89) | 41.0 (17-81) | 49 (32-66) | 59 (34-71) |
| Gender (male/female) | 17/12 | 30/23 | 19/5 | 10/4 |
| ALT (IU/L) | 17.9 (4.7-110.8) | 57.15 (6.7-2260) | 22.8 (7.9-96.9) | 36.65 (15.2-701.6) |
| HBV DNA (log10 IU/mL) |
No test | 3.67 (2.6-8.89) | 2.6 (2.6-6.78) | 2.6 (2.6-6.62) |
| HBsAg (IU/mL) | < 0.05 | 1844 (0.61-52000) | 372.8 (0.23-1991) | 232.5 (2.28-1886) |
| HBsAb (mIU/mL) | 28.3 (2.0-1000) | 2.0 (0.06-119.1) | 2.0 (0.06-110.4) | 2.6 (2.0-467.2) |
| HBeAg (COI) | 0.11 (0.09-0.14) | 14.08 (0.09-1909) | 0.39 (0.09-74.48) | 0.205 (0.09-71.07) |
| HBeAb (COI) | 0.83 (0.00-1.45) | 1.10 (0.00-65.75) | 0.44 (0.0-1.49) | 0.715 (0.0-1.35) |
| HBcAb (COI) | 0.01 (0.01-0.82) | 0.01 (0.01-10.74) | 0.01 (0.01-0.12) | 0.01 (0.01-0.01) |
R, acute resolved patients; CHB, chronic hepatitis B virus; LC, HBV-related liver cirrhosis; HCC, HBV-related hepatocellular carcinoma.
COI, cut off index, COI = sample value/cut off value. COI >1.0 means positive result, COI<1.0 means negative result.